1. |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3): 229-263.
|
2. |
WHO. ICD-10 : international statistical classification of diseases and related health problems: tenth revision, 2nd ed. (2004). [2024-05-20]. https://iris.who.int/handle/10665/42980.
|
3. |
WHO. WHO regional offices. [2024-06-03]. https://www.who.int/about/who-we-are/regional-offices.
|
4. |
Human Development Report 2021–22. Uncertain times, unsettled lives: shaping our future in a transforming world. (2022). [2024-05-28]. https://hdr.undp.org.
|
5. |
UNDP. Human Development Index (HDI). [2024-06-04]. https://hdr.undp.org/data-center/human-development-index#/indicies/HDI.
|
6. |
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer, 2019, 144(8): 1941-1953.
|
7. |
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. Int J Cancer, 2021 Apr 5. doi: 10.1002/ijc.33588.
|
8. |
Richard Doll PP, Waterhouse J. Cancer incidence in five continents: a technical report. Springer Berlin, Heidelberg, 1966.
|
9. |
WHO I. CANCER TODAY: Data and methods. [2024-05-21]. https://gco.iarc.who.int/today/en/data-sources-methods.
|
10. |
Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomarkers Prev, 2019, 28(10): 1563-1579.
|
11. |
辛雯艳, 郭晓莉, 何小双, 等. 1990–2019年我国居民肺癌死亡水平与疾病负担趋势预测研究. 中华肿瘤防治杂志, 2024, 31(2): 65-73.
|
12. |
GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet, 2021, 397(10292): 2337-2360.
|
13. |
新华社. 中共中央国务院印发《“健康中国2030”规划纲要》. (2016-10-25). [2024-06-02]. https://www.gov.cn/zhengce/2016-10/25/content_5124174.htm.
|
14. |
范亚光, 周清华, 乔友林, 等. 中国肺癌低剂量CT筛查指南(2023年版). 中国肺癌杂志, 2023, 26(1): 1-9.
|
15. |
Yang D, Liu Y, Bai C, et al. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett, 2020, 468: 82-87.
|
16. |
Li M, Dal Maso L, Vaccarella S. Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol, 2020, 8(6): 468-470.
|
17. |
Pizzato M, Li M, Vignat J, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol, 2022, 10(4): 264-272.
|
18. |
Cheng F, Xiao J, Shao C, et al. Burden of thyroid cancer from 1990 to 2019 and projections of incidence and mortality until 2039 in China: findings from global burden of disease study. Front Endocrinol (Lausanne), 2021, 12: 738213. doi: 10.3389/fendo.2021.738213.
|
19. |
Lin Y, Wu Y. Trends in incidence and overdiagnosis of thyroid cancer in China, Japan, and South Korea. Cancer Sci, 2023, 114(10): 4052-4062.
|
20. |
Yu C, Tang H, Guo Y, et al. Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study. Ann Intern Med, 2018, 168(7): 489-497.
|
21. |
Conway E, Wu H, Tian L. Overview of risk factors for esophageal squamous cell carcinoma in China. Cancers (Basel), 2023, 15(23): 5604. doi: 10.3390/cancers15235604.
|
22. |
滕熠, 曹毛毛, 严鑫鑫, 等. 1990–2019年早发食管癌疾病负担及变化趋势: 中国与全球对比分析. 中华肿瘤防治杂志, 2024, 31(4): 189-195.
|
23. |
Lin L, Li Z, Yan L, et al. Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019. J Hematol Oncol, 2021, 14(1): 197. doi: 10.1186/s13045-021-01213-z.
|
24. |
Poorolajal J, Moradi L, Mohammadi Y, et al. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health, 2020, 42: e2020004. doi: 10.4178/epih.e2020004.
|
25. |
van den Brandt PA. The impact of a healthy lifestyle on the risk of esophageal and gastric cancer subtypes. Eur J Epidemiol, 2022, 37(9): 931-945.
|
26. |
Jiang Q, Shu Y, Jiang Z, et al. Burdens of stomach and esophageal cancer from 1990 to 2019 and projection to 2030 in China: Findings from the 2019 Global Burden of Disease Study. J Glob Health, 2024, 14: 04025. doi: 10.7189/jogh.14.04025.
|
27. |
de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health, 2020, 8(2): e180-e190. doi: 10.1016/S2214-109X(19)30488-7.
|
28. |
Petrick JL, Florio AA, Znaor A, et al. International trends in hepatocellular carcinoma incidence, 1978-2012. Int J Cancer, 2020, 147(2): 317-330.
|
29. |
Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol, 2019, 16(10): 589-604.
|
30. |
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum, 2007, 90: 1-636.
|
31. |
Bouvard V, Wentzensen N, Mackie A, et al. The IARC perspective on cervical cancer screening. N Engl J Med, 2021, 385(20): 1908-1918.
|
32. |
Maver PJ, Poljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect, 2020, 26(5): 579-583.
|
33. |
WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. (2020). [2024-05-28]. https://www.who.int/publications/i/item/9789240014107.
|
34. |
王苏蒙, 闫慧姣, 任文辉, 等. 中国宫颈癌防控进展. 中国预防医学杂志, 2023, 24(12): 1366-1370.
|
35. |
IARC, IACR. Cancer incidence in five continents. Vol. Ⅻ. (2023). [2024-05-30]. https://ci5.iarc.who.int.
|